NCT06804850 2025-11-19
Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC
West China Hospital
Phase 2 Withdrawn
West China Hospital
Thomas Jefferson University
Case Comprehensive Cancer Center
Eurofarma Laboratorios S.A.
Icahn School of Medicine at Mount Sinai
BioMimetix JV, LLC
European Organisation for Research and Treatment of Cancer - EORTC
Centre Antoine Lacassagne
SWOG Cancer Research Network
AstraZeneca